We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AMPLI market cap is 146.84M. The company's latest EPS is EUR 0.0318 and P/E is 96.23.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 89.39M | 96.53M | 109.43M | 180.95M | 109.93M |
| Operating Income | 1.89M | 1.55M | 4.89M | 56.3M | 13.08M |
| Net Income | -14.2M | -14.1M | -4.39M | 39.25M | 1.53M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 275.21M | 269.07M | 259.46M | 266.02M | 279.26M |
| Total Liabilities | 204.29M | 212.21M | 206.89M | 170.2M | 183.43M |
| Total Equity | 70.91M | 56.87M | 52.57M | 95.81M | 95.82M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 12.38M | 2.34M | 7.98M | 8.1M | 4.04M |
| Investing | -9.58M | -9.16M | -12.41M | 45.54M | -14.42M |
| Financing | 14.76M | 736k | -5.41M | -37.43M | 2.48M |
| Market Cap | 146.84M |
| Price to Earnings Ratio | 96.23 |
| Price to Sales Ratio | 1.34 |
| Price to Cash Ratio | 5.05 |
| Price to Book Ratio | 1.53 |
| Dividend Yield | - |
| Shares Outstanding | 47.99M |
| Average Volume (1 week) | 119 |
| Average Volume (1 Month) | 795 |
| 52 Week Change | -4.97% |
| 52 Week High | 3.58 |
| 52 Week Low | 2.70 |
| Spread (Intraday) | 0.02 (0.65%) |
| Company Name | Amplitude Surgical |
| Address |
11 cours jacques offenbach valence, drome 26000 |
| Website | https://www.amplitude-ortho.com |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
